Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Front Endocrinol (Lausanne). 2023 Oct 20;14:1265152. doi: 10.3389/fendo.2023.1265152. eCollection 2023.
Polycystic ovary syndrome (PCOS) is a multifaceted disorder that impacts metabolism, reproduction, as well as endocrine function, characterized by excessive levels of androgen and insulin resistance. The gut microbiota has been implicated in the pathogenesis of PCOS. However, the precise mechanisms through which the gut microbiota influences PCOS still require further elucidation.
The PCOS mouse model was established through the administration of letrozole to both conventional and antibiotics-treated mice. The evaluation of glucose metabolism, sex hormone levels, and ovarian morphology was conducted. Furthermore, the fecal samples from each group of mice were subjected to 16S rRNA gene sequencing, and functional prediction of gut microbiota was proceeded using PICRUSt2 to explore potential mechanisms.
By using letrozole-induced PCOS mice model, we manifested that antibiotic intervention significantly reduced the serum total testosterone level and ameliorated glucose intolerance. Antibiotic treatment reduced the number of amplicon sequence variants (ASVs), as well as the Shannon and Simpson index. Meanwhile, letrozole induced a significant increase in the Shannon and Simpson index instead of ASVs. Through random forest model analysis, the results revealed significant alterations in three distinct groups of microbiota, namely Clostridia_vadinBB60_group, Enterorhabdus, and Muribaculaceae after letrozole treatment. Further correlation analysis revealed a positive association between alterations in these microbiota and both serum total testosterone levels and the area under the curve (AUC) of blood glucose in IPGTT. The administration of antibiotics led to a decrease in the absolute abundance of 5 ASVs belonging to unclassified Clostridia_vadinBB60_group, unclassified Enterorhabdus, and unclassified Muribaculaceae, which exhibited a positive correlation with the levels of total testosterone in mice serum, as well as the area under the curve of blood glucose in IPGTT. Moreover, 25 functional pathways of gut microbiome were significantly discrepant between the letrozole-treated mice with and without antibiotics.
These results suggest that disturbance of the gut microbiota may take participate in the progression of PCOS and manipulating the composition of the gut microbiota may be a therapeutic approach for managing PCOS.
多囊卵巢综合征(PCOS)是一种多方面的疾病,会影响新陈代谢、生殖以及内分泌功能,其特征是雄激素和胰岛素抵抗水平过高。肠道微生物群与 PCOS 的发病机制有关。然而,肠道微生物群影响 PCOS 的具体机制仍需要进一步阐明。
通过给常规和抗生素处理的小鼠施用来曲唑,建立 PCOS 小鼠模型。评估葡萄糖代谢、性激素水平和卵巢形态。此外,对每组小鼠的粪便样本进行 16S rRNA 基因测序,并使用 PICRUSt2 进行肠道微生物群的功能预测,以探讨潜在的机制。
使用来曲唑诱导的 PCOS 小鼠模型,我们表明抗生素干预可显著降低血清总睾酮水平并改善葡萄糖不耐受。抗生素治疗减少了扩增子序列变异(ASV)的数量,以及 Shannon 和 Simpson 指数。同时,来曲唑诱导的 Shannon 和 Simpson 指数而非 ASV 显著增加。通过随机森林模型分析,结果表明在来曲唑处理后,有 3 组微生物群发生了显著变化,分别是 Clostridia_vadinBB60_group、Enterorhabdus 和 Muribaculaceae。进一步的相关性分析表明,这些微生物群的变化与血清总睾酮水平和 IPGTT 中的血糖 AUC 之间呈正相关。抗生素的给药导致 5 个属于未分类的 Clostridia_vadinBB60_group、未分类的 Enterorhabdus 和未分类的 Muribaculaceae 的 ASV 的绝对丰度下降,这些 ASV 与小鼠血清中的总睾酮水平以及 IPGTT 中的血糖 AUC 呈正相关。此外,来曲唑处理的小鼠与未用抗生素处理的小鼠之间的肠道微生物组有 25 个功能途径存在显著差异。
这些结果表明,肠道微生物群的紊乱可能参与了 PCOS 的进展,而操纵肠道微生物群的组成可能是治疗 PCOS 的一种方法。